Faculty

Institution

Unit

Venue

Aaron Trimble

Oregon Health & Science University

Affiliations

Department of Medicine

Division of Pulmonary & Critical Care

Division Of Pediatric Pulmonology

Division Of Pulmonary, Allergy And Critical Care

Oregon Health & Science University

NoneAaron Trimble is currently serving as a Medicine faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Aaron Trimble

Oregon Health & Science University

You can click a keyword to filter the displayed items

cystic fibrosis pediatrics respiratory medicine pharmacology medicine health sciences veterinary medicine obstetrics and gynaecology pediatric pulmonology neonatology fetal medicine mucociliary clearance maternal health sexual and reproductive health reproductive health reproductive medicine fibrosis prenatal testing pulmonary diseases hypertonic saline medical imaging neuroimaging clinical trials molecular medicine clinical microbiology biomedical imaging pharmacotherapy molecular diagnostics medicinal research pediatric allergy wildland fire critical care clinic intensive care nursing sexual health real world evidence human exposure breastfeeding treatment effects magnetic resonance imaging ventilation clinical evidence maternal-fetal medicine high-risk pregnancies pharmacokinetics prenatal diagnosis genetic testing cytopathology adolescent medicine clinical therapeutics therapeutic efficacy inhalation toxicology respiratory toxicology venous disease sanitation disinfectants fertility tracking respiratory infections sexual responsibility human sexuality reproductive ethics vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor skyline trials neonatal exposure drug exposure ivacaftor withdrawal syndrome prolonged effect week trial clinical outcomes fetal exposures pharmacokinetic models high risk fetal therapy cftr modulator therapies wildfire smoke exposure

Notable Scholarly Works

Notable Federal Grants

Collaborators

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor During Pregnancy Through Physiologically Based Pharmacokinetic Models. Clinical Pharmacology & Therapeutics (2025)

gynecologyhigh-risk pregnanciesobstetrics and gynaecologyfetal exposuresmaternal-fetal medicinepharmacokinetic modelsmaternal healthpharmacologypharmacokineticsclinical researchpharmacotherapyfetal medicine

Prenatal Modulator Treatment to Prevent Cf Complications (Protect) Workshop Report. Journal of Cystic Fibrosis (2025)

medicineobstetrics and gynaecologypediatric pulmonologyfibrosispediatricscystic fibrosisrespiratory medicinemolecular medicine

Routine Cell-Free Dna Prenatal Screening Identifies Pregnancies at High Risk for Cystic Fibrosis That May Benefit From Fetal Therapy. Journal of Cystic Fibrosis (2025)

gynecologymolecular diagnosticsobstetrics and gynaecologyhigh riskmaternal healthcystic fibrosisfetal therapygenetic testinghuman geneticsprenatal testingpathologyprenatal diagnosis

Vanzacaftor–Tezacaftor–Deutivacaftor Versus Elexacaftor–Tezacaftor–Ivacaftor in Individuals With Cystic Fibrosis Aged 12 Years and Older (Skyline Trials Vx20-121-102 and Vx20-121-103): Results From Two Randomised, Active-Controlled, Phase 3 Trials. The Lancet Respiratory Medicine (2025)

Claire KeatingLael M YonkerFrançois VermeulenDario PraisRachel W LinnemannAaron TrimbleTom KotsimbosJoel MermisAndrew T BraunMark O'CarrollSivagurunathan SutharsanBonnie RamseyMarcus A MallJennifer L Taylor-CousarEdward F McKoneElizabeth TullisTim FlorethPeter MichelsonPatrick R SosnayNitin NairRachel ZahigianHannah MartinNeil AhluwaliaAnna LamAlexander Horsley

medicineinfectious diseasesskyline trialsclinical microbiologycystic fibrosisreal world evidencehealth sciencesvanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor

120 Vanzacaftor/Tezacaftor/Deutivacaftor in Adolescents and Adults With Cystic Fibrosis: Results From Two Randomized, Active-Controlled Phase 3 Trials. Journal of Cystic Fibrosis (2024)

C. KeatingL. YonkerF. VermeulenD. PraisR. LinnemannA. TrimbleT. KotsimbosJ. MermisA. BraunM. O'CarrollS. SutharsanB. RamseyM. MallJ. Taylor-CousarE. McKoneE. TullisT. FlorethP. MichelsonN. NairB. YiH. MartinN. AhluwaliaA. LamA. Horsley

fibrosispediatricscytopathologycystic fibrosisadolescent medicinepublic health

Fetal Risk Assessment for Cystic Fibrosis via Fetal Cell Free Dna; a Non-Invasive Pathway to Identify Fetuses Eligible for Cftr Modulator Therapy. (2024)

J WynnKS RaraighS O'RourkeD Chandler-BrownA Trimble

veterinary medicinepediatricscystic fibrosiscftr modulator therapyfetal risk assessmentfetal medicine

Prioritizing Sexual and Reproductive Health Research and Care for People With Cystic Fibrosis: A 2023 Workshop Report From the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (Sharing) Research Working Group. Journal of Cystic Fibrosis (2024)

Traci M KazmerskiChristie MoyEnid AliajJessica HudsonBrandon WrightMaddie PoranskiJacqui SjobergJennifer L. Taylor-CousarAnna M. GeorgiopoulosSigrid L. LadoresAaron TrimbleVin TangprichaFarah Naz KhanRanjith RamasamyDanielle Velez LeitnerNatalie E. WestRochelle Delos SantosOlivia M StranskyAlexandra WilsonAshley KellerRaksha Jain

health sciencesmedicinesexual and reproductive healthcystic fibrosis

Sexual Reproductive Health in Cf – a Shared Responsibility. Journal of Cystic Fibrosis (2024)

gynecologyfertilitysexual responsibilitygender studiesreproductive medicinewomen's healthreproductive ethicsreproductive healthhuman sexualitysexual and reproductive healthsexual health

Assessing the Effectiveness of Surface Cleaning Methods in the Medical Intensive Care Unit. (2023)

disinfectantsintensive care nursingsanitationhospital medicinesurface cleaning methodscritical carepatient safetyemergency medicinecritical care clinic

Diagnostic Confirmation Bias Delaying Cystic Fibrosis Diagnosis and Infertility Treatment. (2023)

diagnosisfertilityinfertility treatmentmedicinefertility trackingcystic fibrosisreproductive medicineinfertilityreproductive healthprenatal testingpathology

1
2
3
10 / page

Aaron Trimble

Oregon Health & Science University

Affiliations

Department of Medicine

Division of Pulmonary & Critical Care

Division Of Pediatric Pulmonology

Division Of Pulmonary, Allergy And Critical Care

Oregon Health & Science University

NoneAaron Trimble is currently serving as a Medicine faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Aaron Trimble

Oregon Health & Science University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor During Pregnancy Through Physiologically Based Pharmacokinetic Models. Clinical Pharmacology & Therapeutics (2025)

Prenatal Modulator Treatment to Prevent Cf Complications (Protect) Workshop Report. Journal of Cystic Fibrosis (2025)

medicineobstetrics and gynaecologypediatric pulmonologyfibrosispediatricscystic fibrosisrespiratory medicinemolecular medicine

Routine Cell-Free Dna Prenatal Screening Identifies Pregnancies at High Risk for Cystic Fibrosis That May Benefit From Fetal Therapy. Journal of Cystic Fibrosis (2025)

gynecologymolecular diagnosticsobstetrics and gynaecologyhigh riskmaternal healthcystic fibrosisfetal therapygenetic testinghuman geneticsprenatal testingpathologyprenatal diagnosis

medicineinfectious diseasesskyline trialsclinical microbiologycystic fibrosisreal world evidencehealth sciencesvanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor

120 Vanzacaftor/Tezacaftor/Deutivacaftor in Adolescents and Adults With Cystic Fibrosis: Results From Two Randomized, Active-Controlled Phase 3 Trials. Journal of Cystic Fibrosis (2024)

fibrosispediatricscytopathologycystic fibrosisadolescent medicinepublic health

Fetal Risk Assessment for Cystic Fibrosis via Fetal Cell Free Dna; a Non-Invasive Pathway to Identify Fetuses Eligible for Cftr Modulator Therapy. (2024)

J WynnKS RaraighS O'RourkeD Chandler-BrownA Trimble

veterinary medicinepediatricscystic fibrosiscftr modulator therapyfetal risk assessmentfetal medicine

health sciencesmedicinesexual and reproductive healthcystic fibrosis

Sexual Reproductive Health in Cf – a Shared Responsibility. Journal of Cystic Fibrosis (2024)

gynecologyfertilitysexual responsibilitygender studiesreproductive medicinewomen's healthreproductive ethicsreproductive healthhuman sexualitysexual and reproductive healthsexual health

Assessing the Effectiveness of Surface Cleaning Methods in the Medical Intensive Care Unit. (2023)

disinfectantsintensive care nursingsanitationhospital medicinesurface cleaning methodscritical carepatient safetyemergency medicinecritical care clinic

Diagnostic Confirmation Bias Delaying Cystic Fibrosis Diagnosis and Infertility Treatment. (2023)

diagnosisfertilityinfertility treatmentmedicinefertility trackingcystic fibrosisreproductive medicineinfertilityreproductive healthprenatal testingpathology

1
2
3
10 / page